Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,158	1,428	1,234	1,042	811	1,203
Market Cap Growth	103.46%	15.76%	18.45%	28.46%	-32.59%	98.17%
Enterprise Value	2,816	1,215	1,046	848	617	840
Last Close Price	41.67	19.78	17.54	14.98	11.77	17.67
PE Ratio	89.26	-	87.60	5.68	-	-
Forward PE	22.22	42.93	-	-	-	-
PS Ratio	5.11	3.37	4.57	4.73	21.04	-
PB Ratio	5.87	3.26	2.81	2.63	4.38	3.86
P/TBV Ratio	6.08	3.38	2.93	2.76	4.89	3.86
P/FCF Ratio	31.05	56.20	93.67	182.67	-	-
P/OCF Ratio	30.71	55.59	92.76	179.37	-	-
EV/Sales Ratio	4.71	2.87	3.87	3.85	16.02	-
EV/EBITDA Ratio	71.04	-	-	69.62	-	-
EV/EBIT Ratio	73.81	-	-	86.73	-	-
EV/FCF Ratio	27.68	47.81	79.39	148.64	-	-
Debt / Equity Ratio	0.02	0.02	0.03	0.02	0.03	0.02
Debt / EBITDA Ratio	0.22	-	-	0.38	-	-
Debt / FCF Ratio	0.10	0.39	0.93	1.04	-	-
Asset Turnover	0.94	0.77	0.55	0.64	0.13	-
Inventory Turnover	8.06	6.58	3.41	3.72	-	-
Quick Ratio	3.27	2.84	3.58	4.48	4.15	10.16
Current Ratio	3.85	3.30	4.34	5.16	4.38	10.46
Return on Equity (ROE)	7.39%	-9.85%	3.37%	63.10%	-63.55%	-60.07%
Return on Assets (ROA)	3.76%	-5.15%	-3.19%	1.76%	-33.63%	-32.57%
Return on Capital (ROIC)	4.80%	-6.34%	-3.69%	2.06%	-38.39%	-35.96%
Return on Capital Employed (ROCE)	6.50%	-9.50%	-5.40%	2.40%	-83.30%	-49.50%
Earnings Yield	1.14%	-3.02%	1.14%	17.60%	-19.48%	-13.42%
FCF Yield	3.22%	1.78%	1.07%	0.55%	-15.63%	-11.37%
Buyback Yield / Dilution	-7.99%	0.69%	-2.13%	-2.69%	-10.89%	-14.42%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q